{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:26:15Z","timestamp":1790868375225,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.cct.2014.04.009","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T05:16:20Z","timestamp":1399007780000},"page":"190-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Web-based trial to evaluate the efficacy and safety of tolterodine ER 4mg in participants with overactive bladder: REMOTE trial"],"prefix":"10.1016","volume":"38","clinical-trial-number":[{"clinical-trial-number":"nct01302938","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Miguel","family":"Orri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig H.","family":"Lipset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradly P.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cct.2014.04.009_bb0005","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ahj.2004.04.049","article-title":"Reducing the costs of phase III cardiovascular clinical trials","volume":"149","author":"Eisenstein","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.cct.2014.04.009_bb0010","series-title":"The Innovator's Prescription: A Disruptive Solution for Health Care","author":"Christensen","year":"2009"},{"key":"10.1016\/j.cct.2014.04.009_bb0015","series-title":"Health Online 2013","author":"Fox","year":"2013"},{"key":"10.1016\/j.cct.2014.04.009_bb0020","series-title":"Mobile Access 2010","author":"Smith","year":"2010"},{"issue":"5","key":"10.1016\/j.cct.2014.04.009_bb0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.1837","article-title":"Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm","volume":"29","author":"Wicks","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.cct.2014.04.009_bb0030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0090-4295(00)01113-4","article-title":"Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder","volume":"57","author":"van Kerrebroeck","year":"2001","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.cct.2014.04.009_bb0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00192-002-1009-0","article-title":"A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder","volume":"14","author":"Swift","year":"2003","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"12","key":"10.1016\/j.cct.2014.04.009_bb0040","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1185\/03007990802537122","article-title":"Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms","volume":"24","author":"Herschorn","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"10.1016\/j.cct.2014.04.009_bb0045","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00192-008-0688-6","article-title":"Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women","volume":"19","author":"Rogers","year":"2008","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"1","key":"10.1016\/j.cct.2014.04.009_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1464-410X.2009.09086.x","article-title":"Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial","volume":"105","author":"Herschorn","year":"2010","journal-title":"BJU Int"},{"issue":"9","key":"10.1016\/j.cct.2014.04.009_bb0055","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1464-410X.2010.09640.x","article-title":"Superior efficacy of fesoterodine over tolterodine extended release with rapid onset: a prospective, head-to-head, placebo-controlled trial","volume":"107","author":"Kaplan","year":"2011","journal-title":"BJU Int"},{"issue":"10","key":"10.1016\/j.cct.2014.04.009_bb0060","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-144-10-200605160-00005","article-title":"The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence","volume":"144","author":"Brown","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cct.2014.04.009_bb0065","series-title":"Investigational New Drug Application. Code of Federal Regulations Title 21, Volume 5, Chapter I, Part 312 (21CFR312)","author":"Investigational New Drug Application","year":"2013"},{"issue":"4","key":"10.1016\/j.cct.2014.04.009_bb0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/01.md.0000172299.72364.95","article-title":"An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia","volume":"84","author":"Jacobs","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"7413","key":"10.1016\/j.cct.2014.04.009_bb0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/bmj.327.7413.484","article-title":"Conducting clinical trials over the internet: feasibility study","volume":"327","author":"McAlindon","year":"2003","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.cct.2014.04.009_bb0080","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.amjmed.2004.06.023","article-title":"Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial","volume":"117","author":"McAlindon","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.cct.2014.04.009_bb0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/009286150403800303","article-title":"From informed consent through database lock: an Interactive clinical trial conducted using the Internet","volume":"38","author":"Eilenberg","year":"2004","journal-title":"Drug Inf J"},{"key":"10.1016\/j.cct.2014.04.009_bb0090","unstructured":"Data on file. Pfizer Inc. New York, NY."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714414000573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714414000573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T02:06:33Z","timestamp":1565402793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714414000573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1551714414000573"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2014.04.009","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Web-based trial to evaluate the efficacy and safety of tolterodine ER 4mg in participants with overactive bladder: REMOTE trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2014.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}